Tarceva and disease progression Patient Reports February 12, 2012

Tarceva Side Effects Report #5125785-0
Tarceva side effect was reported by a Health Professional from UNITED STATES on Oct 10, 2006. Male patient, weighting 180.3 lb, was diagnosed with prostate cancer  and was treated with Tarceva. After drug was administered, patient experienced the following side effects: asthenia, blood culture positive, clostridial infection, culture urine positive, dehydration, disease progression, staphylococcal infection , stent placement, surgical procedure repeated. Tarceva dosage: 150 MG 1 QD. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #5669774-6
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2008. Male patient was diagnosed with prostate cancer  and was treated with Tarceva. After drug was administered, patient experienced the following side effects: coordination abnormal, disease progression, meningeal neoplasm, muscular weakness, neoplasm progression, spinal cord compression. Tarceva dosage: 150 MG QD PO. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #4921262-8
Tarceva side effect was reported by a Health Professional from UNITED STATES on Feb 22, 2006. Female patient, 64 years of age, weighting 142.0 lb, was diagnosed with pancreatic carcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cerebrovascular accident, disease progression, embolic stroke, poverty of speech. Tarceva dosage: 150 MG PO QD. During the same period patient was treated with XELODA, ATIVAN, CLEOCIN, ENBREL, PLAQUENIL, FOLIC ACID, HYDROCORTISONE CREAM, PROCRIT. Patient was hospitalized. Patient died on 01/03/2006.

Tarceva Side Effects Report #5391732-X
Tarceva side effect was reported by a Physician from GERMANY on July 02, 2007. Male patient, 59 years of age, was diagnosed with pancreatic carcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, type 1 diabetes mellitus. Tarceva dosage: unknown. During the same period patient was treated with GEMCITABINE, BISOPROLOL FUMARATE. Patient was hospitalized. Patient recovered.


Tarceva Side Effects Report #4837574-2
Tarceva side effect was reported by a Health Professional from UNITED STATES on Nov 03, 2005. Male patient, 54 years of age, was diagnosed with pancreatic carcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: convulsion, disease progression. Tarceva dosage: 150 MG (QD); ORAL. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #5329866-8
Tarceva side effect was reported by a Pharmacist from UNITED STATES on May 17, 2007. Female patient, 46 years of age, weighting 191.8 lb, was diagnosed with pancreatic carcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, rash erythematous, rash macular. Tarceva dosage: 100 MG DAILY PO. During the same period patient was treated with LISINOPRIL, SENNA, SIMVASTATIN, EFFEXOR, OXYCODONE, ALBUTEROL, GLUCOPHAGE, AMITRIPTYLINE. Patient recovered.

Tarceva Side Effects Report #5448463-7
Tarceva side effect was reported by a Physician from UNITED STATES on Aug 27, 2007. Female patient was diagnosed with pancreatic carcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cardiomyopathy , dilatation ventricular, disease progression, ejection fraction decreased, left atrial dilatation, left ventricular dysfunction, mitral valve incompetence. Tarceva dosage: 100 MG (QD), ORAL. During the same period patient was treated with GEMZAR, TAXOTERE. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #5491402-3
Tarceva side effect was reported by a Physician from CANADA on Oct 03, 2007. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer metastatic and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, rash . Tarceva dosage: (150 MG QD), ORAL. Patient died on 07/05/2007.

Tarceva Side Effects Report #4566386-2
Tarceva side effect was reported by a Health Professional from on Jan 26, 2005. Female patient, 81 years of age, weighting 104.9 lb, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, pericardial effusion, pleuritic pain, productive cough. Tarceva dosage: 150 MG ONE QD ORAL. During the same period patient was treated with ATROVENT, HALDOL, SEROQUEL, DILTIAZEM, SYNTHROID, ISORBIDE, ZANTAC. Patient was hospitalized. Patient died on 01/23/2005.


Tarceva Side Effects Report #5624287-2
Tarceva side effect was reported by a Health Professional from UNITED STATES on Feb 08, 2008. Female patient, 79 years of age, weighting 100.1 lb, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, gastrointestinal infection, large intestine perforation, peritonitis, purulence. Tarceva dosage: 150MG PO DAILY. During the same period patient was treated with BEVACIZUMAB, CEFTRIAXONE, HEPARIN, LEVOTHYROXINE, PREDNISONE, ATENOLOL, FENTANYL, PERCOCET. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #5409382-5
Tarceva side effect was reported by a Physician from CHINA on July 30, 2007. Male patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, haemoptysis, respiratory failure. Tarceva dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died on 06/28/2007.

Tarceva Side Effects Report #5422998-5
Tarceva side effect was reported by a Physician from CHINA on Aug 03, 2007. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cough, disease progression, haemoptysis, pyrexia, respiratory failure, white blood cell count increased. Tarceva dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died.

Tarceva Side Effects Report #4772488-8
Tarceva side effect was reported by a Health Professional from UNITED STATES on Sept 19, 2005. Female patient, 72 years of age, weighting 175.7 lb, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea exertional, metabolic acidosis, oxygen saturation decreased, pleural effusion, pulmonary embolism , pulmonary hilum mass, scan abnormal. Tarceva dosage: 150MG PO QD. During the same period patient was treated with TYLENOL, BETAMETHASONE, DIPROPIONATE, CALCIUM GLUCONATE, CLONIDINE, CLOTRIMAZOLE, COLACE, LEVOXYL. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #5420735-1
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Aug 01, 2007. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cardiac failure, disease progression, dyspnoea, respiratory failure, tachypnoea. Tarceva dosage: 150 MG (QD), ORAL. Patient died on 07/21/2007.


Tarceva Side Effects Report #5811362-2
Tarceva side effect was reported by a Physician from GERMANY on June 26, 2008. Female patient, 69 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: angiogram abnormal, atelectasis, disease progression, eye haemorrhage, gliosis, hypoaesthesia, intervertebral disc protrusion, lymphangiosis carcinomatosa. Tarceva dosage: (100 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, TAXOTERE, PEMETREXED. Patient recovered.

Tarceva Side Effects Report #5511148-2
Tarceva side effect was reported by a Physician from CHINA on Oct 23, 2007. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, interstitial lung disease, lung infection. Tarceva dosage: 150 MG, QD, ORAL. Patient died.

Tarceva Side Effects Report #5068158-1
Tarceva side effect was reported by a Health Professional from UNITED STATES on Feb 23, 2006. Female patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, lung cancer metastatic, malignant neoplasm progression. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with ANTICOAGULANT. Patient died on 01/27/2006.

Tarceva Side Effects Report #4728274-8
Tarceva side effect was reported by a Physician from UNITED STATES on July 12, 2005. Male patient, 64 years of age, weighting 170.0 lb, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, haemoptysis, thrombotic thrombocytopenic purpura. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with VELCADE, DECADRON, METOPROLOL TARTRATE, ZESTORETIC. Patient was hospitalized. Patient died on 07/04/2005.

Tarceva Side Effects Report #5067865-4
Tarceva side effect was reported by a Physician from UNITED STATES on Apr 13, 2006. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, interstitial lung disease, malignant neoplasm progression. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with ANTIBIOTICS. Patient was hospitalized. Patient died.


Tarceva Side Effects Report #4745126-8
Tarceva side effect was reported by a Physician from UNITED STATES on May 11, 2005. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: anorexia, asthenia, blood pressure diastolic decreased, cardiac disorder, cardiac murmur, diarrhoea, disease progression, heart rate increased. Tarceva dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died on 05/24/2005.

Tarceva Side Effects Report #5485607-5
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Sept 26, 2007. Male patient, 57 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cardiac failure, disease progression, face oedema, oedema peripheral, rash . Tarceva dosage: unknown. During the same period patient was treated with INSOMNIA MEDICINE NOS. Patient died on 08/25/2007.

Tarceva Side Effects Report #5093308-0
Tarceva side effect was reported by a Physician from THAILAND on Aug 13, 2006. Female patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: coagulopathy, disease progression, rash , retinal haemorrhage, vision blurred. Tarceva dosage: 150 MG (QD), ORAL. Patient recovered.

Tarceva Side Effects Report #4700966-6
Tarceva side effect was reported by a Physician from on June 08, 2005. Female patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, disease recurrence, haemorrhage, jugular vein thrombosis, lung adenocarcinoma, mass, pneumonia , pulmonary oedema. Tarceva dosage: unknown. During the same period patient was treated with AVASTIN, WARFARIN. Patient died on 04/23/2005.

Tarceva Side Effects Report #4709961-4
Tarceva side effect was reported by a Physician from UNITED STATES on June 22, 2005. Female patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, haemorrhage, jugular vein thrombosis, pneumonia , pulmonary oedema. Tarceva dosage: unknown. During the same period patient was treated with AVASTIN, WARFARIN. Patient died.


Tarceva Side Effects Report #4996869-2
Tarceva side effect was reported by a Pharmacist from UNITED STATES on Apr 21, 2006. Female patient, 50 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: asthenia, cardiac tamponade, dehydration, disease progression, dysphagia, failure to thrive, malignant neoplasm progression, pericardial effusion, pleural effusion. Tarceva dosage: 150MG (QD), ORAL. During the same period patient was treated with ATIVAN, VITAMINS, TRAMADOL, PLAVIX, CELEXA, MEGACE, LIPITOR, RESTORIL. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #5291383-1
Tarceva side effect was reported by a Physician from BELGIUM on Mar 19, 2007. Female patient, 44 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, diarrhoea, disease progression, hepatic neoplasm, non-small cell lung cancer, oesophagitis, procedural complication, rash . Tarceva dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died.

Tarceva Side Effects Report #6071937-5
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 05, 2009. Male patient, weighting 151.0 lb, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: abdominal pain , disease progression, nausea . Tarceva dosage: 150MG QD PO. During the same period patient was treated with BEVACIZUMAB, CRESTOR, TOPROL, ELIGARD, POTASSIUM CHLORIDE, NITRO. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #5241116-X
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 14, 2007. Male patient, 63 years of age, weighting 222.7 lb, was diagnosed with metastatic squamous cell carcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression. Tarceva dosage: 150 MG DAILY. During the same period patient was treated with BEVACIZUMAB, COMBIVENT, DURAGESIC, LASIX, LEVOXYL, NADOLOL, OXYCODONE, REGLAN. Patient died on 02/05/2007.

Tarceva Side Effects Report #4852038-8
Tarceva side effect was reported by a Health Professional from UNITED STATES on Dec 12, 2005. Female patient, 38 years of age, weighting 135.4 lb, was diagnosed with mesothelioma  and was treated with Tarceva. After drug was administered, patient experienced the following side effects: confusional state, disease progression, disorientation, dyspnoea exacerbated. Tarceva dosage: 150 MG PO QD. During the same period patient was treated with BEVACIZUMAB, ALDACTONE, ATIVAN, COMPAZINE, DEXAMETHASONE ELIXER, ELIDEL, LEXAPRO. Patient died on 12/02/2005.


Tarceva Side Effects Report #5578432-8
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 17, 2007. Female patient, 78 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, dysphonia, pyrexia. Tarceva dosage: unknown. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #5900784-7
Tarceva side effect was reported by a Physician from GERMANY on Sept 12, 2008. Male patient, 76 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood glucose increased, blood lactate dehydrogenase increased, blood pressure decreased, cachexia, disease progression, dry skin, gamma-glutamyltransferase increased, gastrointestinal sounds abnormal. Tarceva dosage: unknown. During the same period patient was treated with NAVELBINE, CISPLATIN. Patient died.

Tarceva Side Effects Report #4899479-0
Tarceva side effect was reported by a Pharmacist from UNITED STATES on Oct 07, 2005. Female patient, 76 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, malignant neoplasm progression. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with PANTOPRAZOLE, THYROID. Patient was hospitalized. Patient died.

Tarceva Side Effects Report #5729794-X
Tarceva side effect was reported by a Physician from NETHERLANDS on Apr 17, 2008. Male patient, 73 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, pleural effusion, respiratory tract infection. Tarceva dosage: (150 MG, QD), ORAL. Patient died on 02/28/2008.

Tarceva Side Effects Report #5074862-1
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 14, 2006. Male patient, 71 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, malignant neoplasm progression. Tarceva dosage: 150 MG (QD),ORAL. Patient died on 01/31/2006.


Tarceva Side Effects Report #5073328-2
Tarceva side effect was reported by a Physician from UNITED STATES on Jan 27, 2006. Female patient, 66 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, malignant neoplasm progression, retinal haemorrhage. Tarceva dosage: 150 MG (QD), ORAL. Patient recovered.

Tarceva Side Effects Report #6108676-8
Tarceva side effect was reported by a Physician from CHINA on Feb 20, 2009. Female patient, 64 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, intracranial pressure increased, metastases to central nervous system. Tarceva dosage: (150 MG, QD), ORAL. Patient recovered.

Tarceva Side Effects Report #5389617-8
Tarceva side effect was reported by a Physician from ARGENTINA on June 28, 2007. Female patient, 61 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: asthenia, disease progression, dyspepsia, pneumonia . Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with DOCETAXEL. Patient died.

Tarceva Side Effects Report #5445964-2
Tarceva side effect was reported by a Health Professional from FRANCE on Aug 20, 2007. Male patient, 61 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: blood calcium increased, blood chloride decreased, blood creatinine increased, blood osmolarity decreased, blood potassium increased, blood sodium decreased, coma, disease progression, pancreatitis. Tarceva dosage: unknown. During the same period patient was treated with LANSOPRAZOLE, CLINIMIX. Patient died on 06/29/2007.

Tarceva Side Effects Report #5911488-9
Tarceva side effect was reported by a Health Professional from UNITED STATES on Sept 18, 2008. Female patient, 61 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, respiratory failure. Tarceva dosage: 150 MG, QD, ORAL. Patient died on 09/01/2008.


Tarceva Side Effects Report #5775539-7
Tarceva side effect was reported by a Physician from SWEDEN on May 28, 2008. Male patient, 60 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, embolism. Tarceva dosage: (100 MG,QD), ORAL. During the same period patient was treated with INNOHEP, OXYCONTIN, OXYCODONE, BETAPRED, GABEPENTIN, OMEPRAZOLE, MOVICOL, ZOPICLON. Patient died.

Tarceva Side Effects Report #4899439-X
Tarceva side effect was reported by a Health Professional from UNITED STATES on June 08, 2005. Female patient, 54 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: alopecia, disease progression, malignant neoplasm progression. Tarceva dosage: 150 MG (QD) ORAL. Patient recovered.

Tarceva Side Effects Report #4601254-9
Tarceva side effect was reported by a Physician from on Feb 10, 2005. Female patient, 59 years of age, weighting 160.0 lb, was diagnosed with lung cancer metastatic and was treated with Tarceva. After drug was administered, patient experienced the following side effects: conjunctivitis, disease progression, dyspnoea, rash morbilliform, rash papular, rash vesicular, stomatitis, treatment noncompliance. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with OXYCONTIN, XANAX, LORTAB, EPOGEN, NYSTATIN. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #5878591-3
Tarceva side effect was reported by a Physician from FRANCE on Aug 25, 2008. Female patient, 61 years of age, was diagnosed with lung adenocarcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: confusional state, csf test abnormal, disease progression, no therapeutic response, rash , recurrent cancer. Tarceva dosage: (150 MG, QD), ORAL; (300 MG, QD), ORAL. During the same period patient was treated with METHYLPREDNISOLONE, STEROID NOS, PREDNISONE. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #5797857-9
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on June 24, 2008. Male patient, 46 years of age, was diagnosed with lung adenocarcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, gastric haemorrhage, haemoptysis, occult blood positive, oedema, onychoclasis, pruritus, rash pustular. Tarceva dosage: (150 MG,QD), ORAL. Patient died.

Tarceva Side Effects Report #4984352-X
Tarceva side effect was reported by a Physician from FINLAND on Apr 04, 2006. Female patient, 61 years of age, was diagnosed with gastric cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, intracranial pressure increased, intracranial venous sinus thrombosis, memory impairment, movement disorder , neurological symptom, pyrexia. Tarceva dosage: 100 MG Q 36 HOURS, ORAL. During the same period patient was treated with AVASTIN, DOCETAXEL. Patient died on 02/07/2006.

Tarceva Side Effects Report #5771626-8
Tarceva side effect was reported by a Physician from FRANCE on May 27, 2008. Female patient, 68 years of age, was diagnosed with bronchial carcinoma, oesophagitis and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, gamma-glutamyltransferase increased, oedematous pancreatitis. Tarceva dosage: (150 MG, QD), ORAL. During the same period patient was treated with NEXIUM, LEXOMIL, ACETAMINOPHEN. Patient died.

Tarceva Side Effects Report #4986949-X
Tarceva side effect was reported by a Health Professional from UNITED STATES on Apr 27, 2006. Female patient, 70 years of age, weighting 124.0 lb, was diagnosed with breast cancer metastatic and was treated with Tarceva. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, biliary dilatation, blood bilirubin increased, disease progression, hydronephrosis, mental status changes, renal failure acute. Tarceva dosage: 100 MG QD. During the same period patient was treated with ALBUTEROL SULPHATE, ADVAIR DISKUS, LISINOPRIL, HYDROCODONE, GLIPIZIDE, PHENERGAN, MORPHINE ELIXIR. Patient was hospitalized. Patient died on 04/22/2006.

Tarceva Side Effects Report #5015378-8
Tarceva side effect was reported by a Health Professional from UNITED STATES on May 30, 2006. Female patient, 64 years of age, was diagnosed with breast cancer metastatic and was treated with Tarceva. After drug was administered, patient experienced the following side effects: bile duct obstruction, disease progression, jaundice . Tarceva dosage: 100 MG Q DAY. During the same period patient was treated with HYZAAR, ZOCOR, LEXAPRO, BABY ASP, ATIVAN, COMPAZINE. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #4758740-0
Tarceva side effect was reported by a Health Professional from UNITED STATES on Aug 31, 2005. Female patient, 61 years of age, weighting 148.0 lb, was diagnosed with breast cancer metastatic and was treated with Tarceva. After drug was administered, patient experienced the following side effects: biliary tract disorder, disease progression, hypovolaemia, jaundice , liver function test abnormal, nausea , obstruction, tachycardia. Tarceva dosage: 150 MG PO DAILY. During the same period patient was treated with LETROZOLE, SYNTHROID, VERAPAMIL, NEXIUM, ZESTRIL, HYDROCHLOROTHIAZIDE, CALCIUM W. Patient was hospitalized. Patient recovered.


Tarceva Side Effects Report #5268284-8
Tarceva side effect was reported by a Physician from UNITED STATES on Mar 14, 2007. Female patient, 57 years of age, weighting 217.0 lb, was diagnosed with breast cancer metastatic and was treated with Tarceva. After drug was administered, patient experienced the following side effects: breast cancer metastatic, disease progression, pleural effusion. Tarceva dosage: 150MG DAILY. During the same period patient was treated with LETROZOLE. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #5492787-4
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Oct 05, 2007. Female patient, 56 years of age, was diagnosed with breast cancer metastatic and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, respiratory failure. Tarceva dosage: (150 MG, 1 IN 1 D), ORAL. Patient died.

Tarceva Side Effects Report #5143866-2
Tarceva side effect was reported by a Health Professional from UNITED STATES on Nov 02, 2006. Female patient, 54 years of age, weighting 345.0 lb, was diagnosed with breast cancer  and was treated with Tarceva. After drug was administered, patient experienced the following side effects: axillary mass, body temperature increased, disease progression, infusion site cellulitis. Tarceva dosage: 100 MG PO 1 X DAY. During the same period patient was treated with RAD, DILAUDID, OXYCONTIN, KETAMINE, SENNA, LASIX, LEXAPRO, ALPRAZOLAN. Patient recovered.

Tarceva Side Effects Report #5244959-1
Tarceva side effect was reported by a Health Professional from UNITED STATES on Feb 21, 2007. Female patient, 40 years of age, weighting 133.0 lb, was diagnosed with breast cancer  and was treated with Tarceva. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, disease progression, malaise, scleral discolouration. Tarceva dosage: unknown. During the same period patient was treated with EVEROLIMUS, CYMBALTA, ZOMETA, AMBIEN CR, FLAXSEED OIL, FISH OIL, IBUPROFEN. Patient recovered.

Tarceva Side Effects Report #5483223-2
Tarceva side effect was reported by a Consumer or non-health professional from CANADA on Sept 24, 2007. Male patient, 56 years of age, was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression. Tarceva dosage: unknown. Patient died on 08/13/2007.

Tarceva Side Effects Report #5800771-3
Tarceva side effect was reported by a Consumer or non-health professional from on June 23, 2008. Female patient, 56 years of age, was treated with Tarceva. After drug was administered, patient experienced the following side effects: asthenia, back pain , disease progression, dyspnoea, loss of consciousness, painful respiration. Tarceva dosage: (150 MG,QD),ORAL. Patient was hospitalized. Patient died.

Tarceva Side Effects Report #5067875-7
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 23, 2005. Male patient was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, erythema, malignant neoplasm progression. Tarceva dosage: unknown. Patient died.